STAT

Vaccines don’t work against some viruses. CRISPR might one day fix that

Vaccines don't work against several viral diseases. Now scientists are trying rescue one of the oldest biotechnologies with one of the newest — #CRISPR.
Electron micrograph of a human B cell

Two centuries isn’t a bad run for a medical technology. But while vaccination has prevented hundreds of millions of deaths since 1796, when Edward Jenner inoculated a boy with cowpox to prevent smallpox, there’s clearly room for improvement: Vaccines are risky or ineffective in people with compromised immune systems, they don’t even exist for several viral diseases, and flu vaccines, in particular, often fail in the elderly.

All of which gave scientists in half a dozen labs the same idea: Rescue one of the oldest biotechnologies with one of the newest — CRISPR.

In one study published last month, another posted to the preprint

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About GLP-1 Spending, Biosimilar Patient Costs, And More
Spending on GLP-1 drugs like Ozempic and Wegovy ballooned last year and they're set to cost the U.S. health care system and the federal government still more.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FTC Fighting ‘Junk’ Patents, Pfizer Direct-to-consumer Plans, And More
The FTC expanded its campaign against pharmaceutical companies for filing what it calls “junk” patent listings for 20 different brand-name treatments.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About An Amgen Obesity Drug, A Senate Bill On Shortages, And More
Amgen will no longer develop an early-stage obesity pill, and will instead focus on a more advanced injectable candidate to compete with Wegovy and Zepbound.

Related Books & Audiobooks